Electroconvulsive therapy: overview, procedure, history, uses and ethical issues

How ECT is performed

Before treatment the patient receives short-acting general anesthesia and a muscle relaxant so that the therapeutic seizure occurs without conscious awareness or major motor movement. Electrodes are placed on the scalp in either bilateral (both sides) or unilateral (one side) configurations. A brief electrical pulse (measured in milliseconds) is delivered and a generalized seizure is produced; the seizure itself typically lasts tens of seconds and is monitored with electroencephalography. Practitioners adjust stimulus dose, electrode placement and pulse width to balance efficacy and cognitive side effects.

Indications and clinical use

ECT is most often used for severe or treatment-resistant mood disorders and certain forms of psychosis. Common indications include:

• Severe major depressive disorder, especially with suicidal intent or profound functional impairment
• Acute manic or mixed episodes in bipolar disorder
• Catatonia and some forms of severe psychosis
• When rapid response is needed (e.g., during pregnancy where medications are limited)

Typical courses of acute ECT consist of a series of treatments given two or three times per week over several weeks; some patients receive maintenance sessions at longer intervals to prevent relapse.

Effectiveness and mechanisms

ECT is among the most effective treatments for severe depression and catatonia, often producing faster clinical improvement than antidepressant medications. Its precise biological mechanism is not fully understood but is thought to involve widespread changes in neuronal activity, neurotransmitter systems, and neuroplasticity following the induced seizure.

Risks, side effects and monitoring

Common short-term adverse effects include transient confusion and disorientation immediately after a session and short-term memory problems. Some patients experience retrograde or anterograde memory impairment that typically improves over weeks to months, though persistent memory complaints are reported by a minority. Medical monitoring during and after treatment addresses cardiovascular and respiratory safety. Advances such as unilateral electrode placement and ultrabrief pulse stimulation aim to reduce cognitive side effects while preserving efficacy.

History, stigma and modern practice

ECT was introduced in the late 1930s and became widely used in the mid-20th century. Early practices sometimes lacked anesthesia and muscle relaxation, contributing to a negative public image. Since the later 20th century, improvements in technique, anesthesia and patient selection have made modern ECT a safer and more targeted intervention. Nevertheless, portrayal in media and historical abuses have left enduring stigma.

Ethics, consent and legal issues

Because ECT affects cognition and consciousness, informed decision-making and capacity assessment are central. Clinical guidelines emphasize informed consent, careful documentation, and use of ECT only when clinically indicated. Human-rights advocates and professional bodies debate the use of involuntary ECT and call for safeguards; some international statements and principles address forced or abusive therapies and protections for vulnerable groups, including cautions against coercive treatment of people because of sexual orientation or gender identity (Yogyakarta Principles).

Distinguishing ECT from other neuromodulation

ECT is distinct from nonconvulsive neuromodulation methods such as transcranial magnetic stimulation (TMS) and from surgical approaches like deep brain stimulation (DBS). Compared with TMS, ECT is more likely to produce rapid and robust clinical effects in severe depression but carries greater risks of cognitive side effects.

For more general context about its role in psychiatry see a summary of clinical practice and evidence-based guidelines (psychiatric treatment) and descriptions of the physiological seizure response (seizures). ECT remains a clinically important, evidence-based option for selected patients when used with appropriate safeguards and monitoring.